References
- Paydas S, Seydaoglu G, Ergin M, Erdogan S, Yavuz S. The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas and review of the literature. Leuk Lymphoma 2009; 50: 366–373
- Podar K, Anderson K C. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005; 105: 1383–1395
- Achen M G, McColl B K, Stacker S A. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005; 7: 121–127
- Kadowaki I, Ichinohasama R, Harigae H, Ishizawa K, Okitsu Y, Kameoka J, et al. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol 2005; 130: 869–877
- Ram R, Gafter-Gvili A, Okon E, Pazgal I, Shpiberg O, Raanani P. Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas. Leuk Lymphoma 2007; 48: 2213–2220
- Ganjoo K N, Moore A M, Orazi A, Sen J A, Johnson C S, An C S. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients. J Cancer Res Clin Oncol 2008; 134: 381–387
- Swerdlow, S H, Campo, E, Harris, N L, Jaffe, E S, Pileri, S A, Stein, H, , et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, International Agency for Research on Cancer. 2008
- Paydas S, Ergin M, Erdogan S, Seydaoglu G. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res 2008; 32: 1424–1430